| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w15174 |
| 来源ID | Working Paper 15174 |
| A Quality-Adjusted Price Index for Colorectal Cancer Drugs | |
| Claudio Lucarelli; Sean Nicholson | |
| 发表日期 | 2009-07-23 |
| 出版年 | 2009 |
| 语种 | 英语 |
| 摘要 | The average price of treating a colorectal cancer patient with chemotherapy increased from about $100 in 1993 to $36,000 in 2005, due largely to the approval and widespread use of five new drugs between 1996 and 2004. We examine whether the substantial increase in spending has been worth it. Using discrete choice methods to estimate demand, we construct a price index for colorectal cancer drugs for each quarter between 1993 and 2005 that takes into consideration the quality (i.e., the efficacy and side effects in randomized clinical trials) of each drug on the market and the value that oncologists place on drug quality. A naive price index, which makes no adjustments for the changing attributes of drugs on the market, greatly overstates the true price increase. By contrast, a hedonic price index and two quality-adjusted price indices show that prices have actually remained fairly constant over this 13-year period, with slight increases or decreases depending on a model's assumptions. |
| 主题 | Health, Education, and Welfare ; Health ; Industrial Organization |
| URL | https://www.nber.org/papers/w15174 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/572850 |
| 推荐引用方式 GB/T 7714 | Claudio Lucarelli,Sean Nicholson. A Quality-Adjusted Price Index for Colorectal Cancer Drugs. 2009. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w15174.pdf（312KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
